---
figid: PMC7746821__fcell-08-580140-g001
figtitle: Summary of drug resistance in tumor immunotherapy
organisms:
- Escherichia coli
- Akkermansia muciniphila
- Homo sapiens
- Mus musculus
- gut metagenome
organisms_ner:
- Homo sapiens
- Mus musculus
- Drosophila melanogaster
pmcid: PMC7746821
filename: fcell-08-580140-g001.jpg
figlink: pmc/articles/PMC7746821/figure/F1/
number: F1
caption: Summary of drug resistance in tumor immunotherapy. The mechanisms of drug
  resistance and immune escape in tumor immunotherapy include tumor cell-internal
  and -external factors. The internal factors include loss of tumor antigens and intratumor
  heterogeneity, defects in antigen presentation, abnormal oncogenic signaling and
  IFN-γ signal pathway, innate anti-PD-1 resistance signature, increased expression
  of constitutive PD-L1, epigenetic changes, and lack or exhaustion of T cells. The
  external factors include immunosuppressive cells and cytokines in tumor microenvironment,
  tumor metabolites in immune microenvironment, new immune checkpoints, and intestinal
  microflora. PD-1, programmed death 1; PD-L1, programmed death ligand 1; Anti, Anti-PD1/anti-PDL1;
  HLA, human leukocyte antigen; TCR, T-cell receptor; IFN-γ, interferon-γ; IFN-γR,
  Interferon-γ receptor; Treg, regulatory T cell; Neuropilin-1, neurociliary protein
  1; TAM, tumor associated macrophage; CSF-1, macrophage colony stimulating factor;
  MDSC, myelogenous suppressor cell; IL-6, interleukin-6; TGF-β, transforming growth
  factor-β; TNF, tumor necrosis factor.
papertitle: A Highlight of the Mechanisms of Immune Checkpoint Blocker Resistance.
reftext: Qian Huang, et al. Front Cell Dev Biol. 2020;8:580140.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9318264
figid_alias: PMC7746821__F1
figtype: Figure
redirect_from: /figures/PMC7746821__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7746821__fcell-08-580140-g001.html
  '@type': Dataset
  description: Summary of drug resistance in tumor immunotherapy. The mechanisms of
    drug resistance and immune escape in tumor immunotherapy include tumor cell-internal
    and -external factors. The internal factors include loss of tumor antigens and
    intratumor heterogeneity, defects in antigen presentation, abnormal oncogenic
    signaling and IFN-γ signal pathway, innate anti-PD-1 resistance signature, increased
    expression of constitutive PD-L1, epigenetic changes, and lack or exhaustion of
    T cells. The external factors include immunosuppressive cells and cytokines in
    tumor microenvironment, tumor metabolites in immune microenvironment, new immune
    checkpoints, and intestinal microflora. PD-1, programmed death 1; PD-L1, programmed
    death ligand 1; Anti, Anti-PD1/anti-PDL1; HLA, human leukocyte antigen; TCR, T-cell
    receptor; IFN-γ, interferon-γ; IFN-γR, Interferon-γ receptor; Treg, regulatory
    T cell; Neuropilin-1, neurociliary protein 1; TAM, tumor associated macrophage;
    CSF-1, macrophage colony stimulating factor; MDSC, myelogenous suppressor cell;
    IL-6, interleukin-6; TGF-β, transforming growth factor-β; TNF, tumor necrosis
    factor.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IL6
  - TNF
  - TRBV20OR9-2
  - TRA
  - TRB
  - TRD
  - TRG
  - TGFB1
  - TGFB2
  - TGFB3
  - CSF1
  - TAM
  - STIM1
  - CD274
  - PDCD1
  - RPL17
  - RPL17-C18orf32
  - LAG3
  - HAVCR2
  - KLRC1
  - TIGIT
  - PBRM1
  - ADAR
  - ATM
  - PTPN2
  - CD47
  - CD24
  - Il6
  - Tnf
  - Trav6-3
  - Tgfb1
  - Ltbp1
  - Csf1
  - Cd274
  - Pdcd1
  - Lag3
  - Havcr2
  - Klrc1
  - Tigit
  - Pbrm1
  - Adar
  - Atm
  - Tpm1
  - Ptpn2
  - Cd47
  - Cd24a
  - sm
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - mid
  - Smurf
  - egr
  - Tcr
  - dpp
  - gbb
  - put
  - mav
  - PolG1
  - pyd
  - tefu
  - so
  - 'On'
  - TCR
  - TAM
  - NKG2A
  - tumor
  - intra-tumor
---
